Hepatitis C virus (HCV) is a big problem in prisons. Many people behind bars have it. It is a serious health issue that needs attention. Opioid agonist treatment (OAT) is a helpful tool. It can lower the chance of HCV spreading in the community. But what happens when people are locked up? How do they handle the risk of getting HCV again? And how do they use OAT...

The opioid crisis has been a major public health issue since 2017. It is still a big problem. During this time, there were 164 disasters that cost 1 billion dollars or more. These events can be very tough on people who use drugs. But, how well do opioid treatment programs handle these disasters? This is an important question. The goal is to make these programs strong...

Injectable opioid agonist treatment, or iOAT, is a game-changer for people struggling with opioid addiction. It's patient-focused and backed by solid evidence. But there's a catch. We don't know much about what makes iOAT work or what stops it from being successful. This study dives into the challenges of using diacetylmorphine and hydromorphone for iOAT. It aims to ...